Luxembourg - Lipid Modifying Medicine Use
Since 2014, Luxembourg Lipid Modifying Medicine Use fell by 2% year on year. At 105 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 18 comparing other countries in Lipid Modifying Medicine Use. Luxembourg is overtaken by Hungary, which was number 17 at 111.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Italy with 96.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark lead the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, +3.5% compared to 2018. United Kingdom, Norway and Belgium respectively ranked number 2, 3 and 4 in this ranking. Lithuania witnessed the best average annual growth at +18.8% per year, while Slovakia was the worst growing country at -8.7% per year.
Loading...
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 105.00 |
2018 | 106.30 |
2017 | 109.80 |
2016 | 113.50 |
2015 | 117.30 |
How does Luxembourg rank in Lipid Modifying Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Denmark
|
160 | 2019 | +3.5 % | +3.8 % | View data | |
2 |
#2
United Kingdom
|
153 | 2019 | +1.7 % | +2.3 % | View data | |
17 |
#17
Hungary
|
112 | 2019 | +1.5 % | +1.4 % | View data | |
18 |
#18
Luxembourg
|
105 | 2019 | -1.2 % | -2.0 % | View data | |
19 |
#19
Italy
|
97 | 2019 | +4.2 % | +4.1 % | View data |